The number of confirmed and suspected cases of invasive meningococcal disease in Kent, England, has increased to 34, according to the UK Health Security Agency (UKHSA). This represents an increase from 29 cases reported earlier in the week.
Rising Case Numbers Prompt Response
Of the 34 cases, 23 have been clinically verified, while 11 remain under investigation. Tragically, two people have died as a result of the outbreak. The UKHSA continues to investigate the outbreak and monitor for new cases.
Vaccination and Antibiotic Efforts
Efforts are underway to provide antibiotics to close contacts of confirmed or suspected cases. Students at the University of Kent’s Canterbury Campus, including those who have returned home, are as well being offered preventative antibiotics and vaccination. Some staff living or working in these Halls of Residence are also eligible.
What Could Happen Next
The UKHSA is continuing its investigation and enhanced surveillance. It is likely that the agency will continue to monitor case numbers closely and adjust its response as needed. Further genetic analysis of the strain could provide additional insights into the outbreak’s origin and transmission. A possible next step could involve expanding the vaccination offer to additional groups if the outbreak continues to spread.
Frequently Asked Questions
What type of meningococcal disease is involved in this outbreak?
The current outbreak in Kent has been linked to the MenB strain.
How is the disease spread?
Transmission of MenB requires close and prolonged contact, including living in the same household and intimate contact such as kissing or sharing drinks or vapes.
How many vaccinations have been given?
As of 5pm on Friday, March 20, 2026, 4,500 vaccinations have been given.
What questions do you have about public health responses to infectious disease outbreaks?
